COL1A2 did not distinguish the survival differences of overall, progression, and post-progression in the whole groups of lung cancer patients (Fig. S7D), However, it did actually accurately and efficiently in early staged lung adenocarcinoma (Fig. S7D). Here, COL1A2 is linked to lung carcinoma.